A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
Calibrating scores of an AI algorithm can help clinicians identify patients with a high risk of developing hypertrophic cardiomyopathy, or HCM ,a type of heart disease, and quantify the risk they face ...
LONDON, Aug. 27, 2021 /PRNewswire/ -- Brytlyt are pleased to announce they have been granted a patent by the United States Patent and Trademark Office for their ground-breaking algorithm that allows ...